← all drugs
Glycopyrrolate Injection
being discontinued · Anesthesia · Snapshot: 2026-10-09
- Manufacturers listed
- Fresenius Kabi USA, LLC
- Machine-readable
- JSON for this drug
Presentations (4)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02) | Fresenius Kabi USA, LLC | unknown | 07/30/2026 |
| Glycopyrrolate, Injection, .2 mg/1 mL (NDC 63323-578-01) | Fresenius Kabi USA, LLC | unknown | 07/30/2026 |
| Glycopyrrolate, Injection, 1 mg per 5 mL (NDC 63323-578-05) | Fresenius Kabi USA, LLC | unknown | 07/30/2026 |
| Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01) | Fresenius Kabi USA, LLC | unknown | 07/30/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.